Chemistry:CYP-LAD
From HandWiki
CYP-LAD, also known as 6-cyclopropyl-6-nor-lysergic acid diethylamide or as TRALA-22, is a lysergamide and analogue of lysergic acid diethylamide (LSD).[1] It was patented by Daniel Trachsel and colleagues in 2023 as an LSD analogue with modified LSD-like action,[1] and had also previously been claimed in a 2022 patent by Gilgamesh Pharmaceuticals.[2]
See also
- Substituted lysergamide
- CPM-LAD
References
- ↑ 1.0 1.1 Trachsel D, Liechti ME, Lustenberger F, "Lysergic acid derivatives with modified LSD-like action", US patent 2023/0414583, published 28 December 2023
- ↑ Kruegel AC. Novel Ergolines and Methods of Treating Mood Disorders. Patent WO 2022/226408
External links
 |  |
